Alcon Q3 Performance: Analyst Estimates Show 4.9% Decline in EPS, 6.5% Increase in Revenues

Alcon (ALC) is expected to report Q3 earnings of $0.77 per share, down 4.9% YoY, and revenues of $2.59 billion, up 6.5% YoY. The consensus EPS estimate has remained unchanged over the past 30 days. Analysts expect "Net Sales- Total Surgical" to reach $1.42 billion, "Net Sales- Total Vision care" to reach $1.17 billion, and "Net Sales- Total Surgical- Consumables" to reach $743.89 million. Other key metrics include "Net Sales- Total Surgical- Equipment/other" at $245.51 million, "Net Sales- Total Vision Care- Contact lenses" at $724.58 million, and "Net Sales- Total Vision Care- Ocular health" at $448.60 million.